Key result
Gadolinium-enhanced cardiac magnetic resonance imaging identified cardiac sarcoidosis in 11 of 20 patients, including 3 who did not meet the standard Japanese Ministry of Health and Welfare criteria.
Why the study?
Does Gad-CMR improve the diagnosis of cardiac sarcoidosis compared to JMHW criteria in patients with systemic sarcoidosis?
Population
n=20 patients with biopsy-proven systemic sarcoidosis referred for Gad-CMR scanning to evaluate potential…
Comparison
Gadolinium-enhanced cardiac magnetic resonance… vs Japanese Ministry of Health and Welfare criteria…
Design
Cohort
Authors
Loading...
May identify cardiac sarcoidosis missed by JMHW criteria; hypothesis-generating for improved diagnosis pending prospective validation.
Observational (n=20)
No
Does Gad-CMR improve the diagnosis of cardiac sarcoidosis compared to JMHW criteria in patients with systemic sarcoidosis?
Absolute Event Rate: 55% vs 40%
Gad-CMR identifies potential cardiac involvement in systemic sarcoidosis patients who do not meet traditional JMHW diagnostic criteria.
Manins et al. (2008) conducted an observational in Systemic sarcoidosis (n=20). Gadolinium-enhanced cardiac magnetic resonance imaging (Gad-CMR) vs. Japanese Ministry of Health and Welfare (JMHW) criteria was evaluated on Diagnosis of cardiac sarcoidosis. Gadolinium-enhanced cardiac magnetic resonance imaging identified cardiac sarcoidosis in 11 of 20 patients, including 3 who did not meet the standard Japanese Ministry of Health and Welfare criteria.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: